US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

Leo Pharma Sues Perrigo Israel Over Generic Taclonex

By Dan Rivoli · February 16, 2011, 5:18 PM EST

Leo Pharma A/S has sued generic-drug maker Perrigo Israel Pharmaceuticals Ltd. to block it from selling its own version of the Danish company's Taclonex ointment, used to treat the skin disease...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Leo Pharma A/S v. Perrigo Isrel Pharma Ltd.

Case Number

1:11-cv-00963

Court

New York Southern

Nature of Suit

Patent

Date Filed

February 14, 2011

Featured Stories

What Kaiser's D&O Win Means For 'Return Of Funds' Fights No Photo Available

Abraham Gross

A California federal judge's ruling that the Kaiser Foundation Health Plan was not automatically prohibited from claiming coverage for... (more story)

Merck Drug Price Row Loss, $56M Biotech Verdict And More No Photo Available

Gianna Ferrarin

Law360 Healthcare Authority looks at a D.C. federal court's rejection of Merck's challenge to the Medicare drug price negotiation prog... (more story)

Hospitals Lean On Payors Amid ACA, Medicaid Cuts No Photo Available

Yeji Jesse Lee

Hospitals feeling a mounting financial squeeze are getting more aggressive in contract negotiations and reimbursement disputes with in... (more story)